CoQ10 100 mg

CoQ10 100 mg

NOW4.8 (7,949 ratings)
Format:Capsule Quantity: 90 Capsule(s) · 90 servings
Goals

Product analysis

57 out of 100

CoQ10 100 mg may offer limited support for blood-vessel function and blood-fat measures in selected adults. The unspecified CoQ-10 and hawthorn preparations make comparison with particular extracts harder.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The CoQ-10 and hawthorn preparations are unspecified. Their absorption and equivalence to particular researched preparations cannot be judged confidently.

Ingredient Transparency63

Both ingredient amounts are clearly stated for serving comparisons. Their forms are not identified, leaving the preparation details unclear.

Value For Money75

CoQ-10 is reasonably priced and hawthorn is economical relative to the cost of a full serving. The favorable cost does not establish an added benefit from combining them.

Customer Satisfaction92

Customer ratings are very positive across a large number of reviews. The volume provides a broad view of satisfaction.

Product Focus64

The combination has a cardiovascular-support purpose, with limited and mixed support from CoQ-10. Generic hawthorn cannot be assumed to reproduce the effects of specific extracts used in selected health conditions.

Format
Capsule
Container
90 Capsule(s)
Per serving
$0.22
Customer rating
4.8 · 7,949 ratings
Report analysis

Goals

Heart Health
Impact
Highest effect
B+ Ingredient FitC PathwaysA+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 has limited support for selected blood-pressure, blood-lipid and blood-vessel measures in specific adult populations. Results are mixed, including a trial that found no significant improvement in its main blood-pressure measure. The declared active amount can be compared with conventional oral CoQ10 exposures, without establishing a delivery advantage or prevention of cardiovascular events. Ordinary hawthorn berry cannot be assumed to reproduce findings from standardized extracts used in heart-failure trials.

How this product is rated for Heart Health

Ingredient fit84

CoQ10 provide the principal connection to heart health. Their declared amounts provide differing levels of coverage of the supplied comparison ranges.
Goal fit
CoQ10 give the formula a focused connection to blood-vessel function.
Dose adequacy
CoQ10 and hawthorn both contribute at their declared amounts, below their full comparison levels.

Pathways60

The findings center on blood-vessel function. This is a concentrated contribution rather than coverage of several heart-related routes.
Depth
CoQ10 concentrate the findings on blood-vessel function.
Breadth
The findings cover blood-vessel function, with no comparable coverage of the other assessed routes.

Evidence98

CoQ10 has limited human evidence for selected vascular measures; applicability depends on the studied population.
Evidence strength
CoQ10 supplies the strongest evidence contribution, based on limited trials in selected populations.
Studied preparation
The saved comparison accepts the preparations, but ordinary hawthorn berry cannot be equated with standardized extracts used in clinical trials.

Formulation logic100

No unmet partner requirement or listed stimulant or high-sodium conflict was identified. The ingredients counted for amount coverage reach the supplied comparison threshold.
Partner coverage
The contributing ingredients have no unmet partner requirement in the supplied findings.
Conflicts
No listed caffeine, stimulant or high-sodium conflict was identified in the supplied facts.
Effective doses
The counted ingredients meet the saved amount-comparison threshold; this is not proof of clinical effectiveness.
Study evidence
Hawthorn Supportive 27 studies
Inflammation
Impact
Moderate effect
D+ Ingredient FitF PathwaysA EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q10 has a limited connection to inflammation through changes in certain inflammation markers. That connection concerns people with coronary artery disease who were taking statins, so it doesn't show what to expect in everyday use. Changes in markers also don't tell you whether you'll feel less pain or other inflammatory symptoms.

How this product is rated for Inflammation

Ingredient fit52

Coenzyme Q10 is the ingredient with a relevant, but context-dependent, connection to inflammation.
Goal fit
Coenzyme Q10 is the ingredient with a relevant, but context-dependent, connection to inflammation. Hawthorn has no distinct anti-inflammatory benefit identified here.
Dose adequacy
The serving declares 100 mg CoQ10, below the 300 mg comparison amount; serving frequency is not specified.

Pathways13

The relevant connection is oxidative and mitochondrial stress, involving reactive molecules and the parts of cells that use energy.
Depth
The relevant connection is oxidative and mitochondrial stress, involving reactive molecules and the parts of cells that use energy.
Breadth
The connection is concentrated in oxidative stress rather than spanning several distinct inflammation-related processes.

Evidence93

Coenzyme Q10 has limited relevance to inflammation markers in people with coronary artery disease taking statins. Ordinary CoQ10 corresponds to ubiquinone; a different redox form is not specified.
Evidence strength
Coenzyme Q10 has limited relevance to inflammation markers in people with coronary artery disease taking statins.
Studied preparation
Ordinary CoQ10 corresponds to ubiquinone; a different redox form is not specified.

Formulation logic100

The relevant ingredient can act without an additional partner. No particular ingredient conflict is identified.
Partner coverage
No additional partner ingredient is required for the relevant ingredient’s individual role.
Conflicts
No particular ingredient conflict is identified.
Effective doses
The serving declares 100 mg CoQ10, below the 300 mg comparison amount; serving frequency is not specified.
Study evidence
Longevity
Impact
Lower effect
C- Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg
Study evidence
Impact
Highest effect
B+ Ingredient FitB- PathwaysA- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mgHawthorn · 400 mg

CoQ10 has limited blood-pressure, lipid and vessel-lining marker findings in dyslipidemia, though the unspecified preparation limits comparison with studied products. Hawthorn received vascular-tone recognition in the saved result, but generic hawthorn cannot inherit findings for the specific extract studied in treated heart failure. The combination received partial amount recognition and does not establish prevention of cardiovascular events or extra benefit from combining the ingredients.

How this product is rated for Cardiovascular Support

Ingredient fit83

CoQ10 and hawthorn provide a relatively focused ingredient selection.
Goal fit
CoQ10 and hawthorn provide a relatively focused ingredient selection.
Dose adequacy
The contributing amounts received partial recognition.

Pathways73

Vessel-lining nitric-oxide function was the strongest saved finding. Vessel-lining function and vascular tone reached the saved coverage criteria.
Depth
Vessel-lining nitric-oxide function was the strongest saved finding; coverage does not prove clinical benefit.
Breadth
Vessel-lining function and vascular tone reached the saved coverage criteria.

Evidence88

CoQ10 drove the saved evidence finding; the supplied research limits interpretation to its studied population and outcomes.
Evidence strength
CoQ10 drove the saved evidence finding; the supplied research limits interpretation to its studied population and outcomes.
Studied preparation
The saved result recognized the contributing preparations; this does not establish equivalence of every form or outcome.

Formulation logic100

No required partner was missing and no listed conflict was matched. The contributing ingredients met the saved minimum amount criterion.
Partner coverage
No contributing ingredient lacked a required partner; this does not establish synergy.
Conflicts
No listed ingredient conflict was matched in the saved result.
Effective doses
All contributing ingredients met the saved minimum amount criterion; this does not establish a clinically effective cardiovascular dose.
Study evidence
Hawthorn Supportive 28 studies
Metabolism Support
Impact
Moderate effect
C- Ingredient FitF PathwaysB- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q-10 helps transfer electrons inside mitochondria, the parts of your cells involved in producing usable energy. That normal role doesn't tell us that taking extra CoQ10 makes your whole body burn more energy. Whether it raises metabolic rate when nutrient needs are already met is unclear; changes in metabolic markers aren't the same as a faster rate of energy use.

How this product is rated for Metabolism Support

Ingredient fit59

Coenzyme Q-10 participates in cellular energy production; that role differs from increasing whole-body energy use.
Goal fit
Coenzyme Q-10 has a connection to normal energy processes, which differs from a guaranteed rise in metabolic rate.
Dose adequacy
Coenzyme Q-10: 100 mg per label serving; the amount alone doesn't show that metabolic rate will rise.

Pathways17

Coenzyme Q-10 relates to mitochondrial energy production. Cellular energy handling is different from a demonstrated rise in whole-body energy expenditure.
Depth
Coenzyme Q-10 participates in mitochondrial electron transport, a normal step in cellular energy production.
Breadth
The relevant connection concerns mitochondrial energy handling; several distinct energy-burning effects are not demonstrated.

Evidence75

The ingredients have recognized metabolic roles. Those roles and changes in metabolic markers do not show that extra supplementation increases whole-body energy use.
Evidence strength
Coenzyme Q-10’s cellular energy role does not show a routine increase in whole-body energy expenditure.
Studied preparation
No preparation mismatch is identified for the relevant nutrients; this does not imply that extra amounts accelerate metabolism.

Formulation logic100

No particular ingredient conflict or missing required partner is identified.
Partner coverage
No missing required ingredient partner is identified.
Conflicts
No particular ingredient conflict is identified.
Effective doses
Coenzyme Q-10: 100 mg per serving, compared with the 200 mg reference amount; that comparison is not proof of benefit.
Study evidence
Energy
Impact
Lower effect
C- Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg
Study evidence

Ingredients

IngredientAmount per servingScore
Coenzyme Q10
100 mg 46
Hawthorn Berry
400 mg 52
Gluten Free Adults 18–50 Vegan Kosher Dairy Free Vegetarian
Report overview
Coenzyme Q-10 · 100 mg OverallScore46
F Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyC Value
Each serving provides 100 mg of CoQ10. Its molecular form is not identified in the saved facts, limiting comparison by form.
How this ingredient is rated

Active Ingredient Quality & Bioavailability12

The saved facts do not identify the CoQ10 as ubiquinol or ubiquinone, limiting comparison by form. No liposomal, micellar, nanoemulsion, or black pepper extract claim is recorded in the saved facts.
Molecular Form: Ubiquinol vs. Ubiquinone
The saved facts do not identify the CoQ10 as ubiquinol or ubiquinone, limiting comparison by form.
Formulation & Absorption Enhancers
No liposomal, micellar, nanoemulsion, or black pepper extract claim is recorded in the saved facts.

Dose, Safety & Label Transparency72

Each serving provides 100 mg of CoQ10.
Clinical Dosage Alignment
Each serving provides 100 mg of CoQ10.
Label Transparency & Fillers
The amount is recorded as 100 mg per serving; the evaluation does not flag the listed filler or additive concerns.

Value60

A whole-product serving costs about $0.23.
Price Per Effective Serving
A whole-product serving costs about $0.23.
Hawthorn · 400 mg OverallScore52
F Composition And Label DisclosureA+ Commercial Price And Usability
Each serving provides 400 mg of hawthorn berry. The saved facts do not identify a marker percentage, preparation ratio, or hawthorn species.
How this ingredient is rated

Composition and Label Disclosure29

The berry amount is available, but the saved facts give no marker percentage, preparation ratio, or species name.
Marker and Preparation Disclosure
The saved facts give no marker percentage or preparation ratio for the hawthorn berry.
Species Name Disclosure
The saved facts do not identify a hawthorn species.

Composition and Label Disclosure

No separate rules were evaluated in this group.

Commercial Price and Usability100

A whole-product serving costs about $0.23; the price is not specific to hawthorn.
Commercial Price per Labeled Serving
A whole-product serving costs about $0.23; the price is not specific to hawthorn.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
    Liu Z; Tian Z; Zhao D; Liang Y; Dai S; Liu M; Hou S; Dong X; Zhaxinima; Yang Y · The Journal of clinical endocrinology and metabolism · 2022
    Meta-analysis2,794 participants50 studies pooledCardiovascular Support Heart Health forCoenzyme Q-10
  2. Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
    Vrentzos E; Ikonomidis I; Pavlidis G; Katogiannis K; Korakas E; Kountouri A; Pliouta L; Michalopoulou E; Pelekanou E; Boumpas D; Lambadiari V · Cardiovascular diabetology · 2024
    Randomized trial60 participantsCardiovascular Support forCoenzyme Q-10
  3. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP; Q-SYMBIO Study Investigators · JACC. Heart failure · 2015
    Randomized trial420 participantsCardiovascular Support forCoenzyme Q-10
  4. [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
    Mareev VY; Mareev YV; Begrambekova YL · Kardiologiia · 2022
    Meta-analysis1,139 participants6 studies pooledCardiovascular Support forCoenzyme Q-10
  5. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
    Mortensen AL; Rosenfeldt F; Filipiak KJ · Cardiology journal · 2020
    Randomized trialCardiovascular Support forCoenzyme Q-10
  6. Real world effectiveness of Hawthorn special extract WS 1442 in a retrospective cohort study from Germany.
    Wyss C; Gündling PW; Kostev K · Scientific reports · 2024
    Cohort study9,100 participantsCardiovascular Support forHawthorn
  7. Hawthorn (Crataegus spp.) Clinically Significantly Reduces Blood Pressure in Hypertension: A Meta-Analysis of Randomized Placebo-Controlled Clinical Trials.
    Szikora Z; Mátyus RO; Szabó BV; Csupor D; Tóth B · Pharmaceuticals (Basel, Switzerland) · 2025
    Meta-analysis428 participants6 studies pooledCardiovascular Support Heart Health forHawthorn
  8. A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
    Degenring FH; Suter A; Weber M; Saller R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2003
    Randomized trial143 participantsCardiovascular Support forHawthorn
  9. [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
    Weikl A; Assmus KD; Neukum-Schmidt A; Schmitz J; Zapfe G; Noh HS; Siegrist J · Fortschritte der Medizin · 1996
    Randomized trial136 participantsCardiovascular Support forHawthorn
  10. Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
    Habs M · Forschende Komplementarmedizin und klassische Naturheilkunde = Research in complementary and natural classical medicine · 2005
    Cohort study952 participantsCardiovascular Support forHawthorn
  11. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
    Qu H; Guo M; Chai H; Wang WT; Gao ZY; Shi DZ · Journal of the American Heart Association · 2019
    Meta-analysis575 participants12 studies pooledEnergy forCoenzyme Q-10
  12. Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
    Fernandes MSS; Fidelis DEDS; Aidar FJ; Badicu G; Greco G; Cataldi S; Santos GCJ; de Souza RF; Ardigò LP · Nutrients · 2026
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  13. Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tsai IC; Hsu CW; Chang CH; Tseng PT; Chang KV · Frontiers in pharmacology · 2024
    Meta-analysis1,126 participants13 studies pooledEnergy forCoenzyme Q-10
  14. Antifatigue effects of coenzyme Q10 during physical fatigue.
    Mizuno K; Tanaka M; Nozaki S; Mizuma H; Ataka S; Tahara T; Sugino T; Shirai T; Kajimoto Y; Kuratsune H; Kajimoto O; Watanabe Y · Nutrition (Burbank, Los Angeles County, Calif.) · 2008
    Randomized trial17 participantsEnergy forCoenzyme Q-10
  15. Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
    Mehrabani S; Askari G; Miraghajani M; Tavakoly R; Arab A · Complementary therapies in medicine · 2019
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  16. Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
    Sabbatinelli J; Orlando P; Galeazzi R; Silvestri S; Cirilli I; Marcheggiani F; Dludla PV; Giuliani A; Bonfigli AR; Mazzanti L; Olivieri F; Antonicelli R; Tiano L · Nutrients · 2021
    Randomized trial51 participantsHeart Health forCoenzyme Q-10
  17. Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zhao D; Liang Y; Dai S; Hou S; Liu Z; Liu M; Dong X; Zhan Y; Tian Z; Yang Y · Advances in nutrition (Bethesda, Md.) · 2022
    Meta-analysis1,831 participants26 studies pooledHeart Health forCoenzyme Q-10
  18. Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
    Zhang Z; Liu Z; Geng Y; Huang Y; Hu R; Li F; Song Y; Zhang M · Journal of diabetes research · 2026
    Meta-analysis3,422 participants64 studies pooledHeart Health Metabolism Support forCoenzyme Q-10
  19. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
    Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W · Journal of clinical lipidology · 2019
    Randomized trial101 participantsHeart Health forCoenzyme Q-10
  20. [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
    Rietbrock N; Hamel M; Hempel B; Mitrovic V; Schmidt T; Wolf GK · Arzneimittel-Forschung · 2001
    Randomized trial88 participantsHeart Health forHawthorn